Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

International Biotechnology Trust (IBT) Ordinary 25p Shares

Sell:804.00p Buy:810.00p 0 Change: No change
Market closed Prices as at close on 10 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:804.00p
Buy:810.00p
Change: No change
Market closed Prices as at close on 10 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:804.00p
Buy:810.00p
Change: No change
Market closed Prices as at close on 10 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
798.00p
Trade high:
811.20p
Year high:
812.00p
Estimated NAV:
804.42
Previous close:
806.00p
Trade low:
798.00p
Year low:
451.00p
Premium/Discount:
0.20%
Previous:
0.00p (0.00%)
Previous:
0.00p
Volume:
89,227
Dividend yield:
1.54%
Currency:
GBX
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
INT.BIOTECH. performance chart

Premium/Discount

INT.BIOTECH. performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 2.54% 1 year 1Y 22.12%
1 month 1M 16.47% 2 years 2Y 23.24%
3 months 3M 28.75% 3 years 3Y 33.44%
6 months 6M 28.75% 5 years 5Y 45.23%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: FTSE All Share TR GBP
Annual management charge: 0.9% of Net Assets
Performance fee: Yes
Ongoing charge: 1.68%
Dividend yield: 1.54%
Dividend frequency: Semi-Annually
Total assets: £309m
Gross gearing: 100%
Market capitalisation:Market cap.: £309m
Shares in issue: 38.36 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB0004559349

Recent dividends paid or declared by International Biotechnology Trust:

Type Ex-div date Payment date Amount
2nd interim * 16/07/2020 28/08/2020 12.40p
Interim 19/12/2019 31/01/2020 12.40p
Final 18/07/2019 30/08/2019 14.00p
Interim 20/12/2018 31/01/2019 14.00p
Final 02/08/2018 31/08/2018 13.50p

* Dividend has not yet been paid but has been declared by International Biotechnology Trust.

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual International Biotechnology Trust dividends:

Financial
year end
Dividend
yield
Dividend
cover
Total dividend
paid
31/08/2019 4.40% -0.20 28.00p
31/08/2018 4.00% -0.26 27.00p
31/08/2017 4.00% -0.20 23.00p
31/08/2016 2.30% -0.58 n/a
31/08/2015 n/a n/a n/a

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents



Objective

The objective is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. The company invests in companies that are considered to be good value with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

NET ASSET VALUE (NAV)

Estimated NAV: 804.42
Latest actual NAV: 804.54
Latest actual NAV date: 9 July 2020
Premium/Discount: 0.20%
12m average Premium/Discount: -2.75%
NAV frequency: Daily

Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

Security Weight
Vertex Pharmaceuticals Inc 6.30%
Gilead Sciences Inc 6.03%
Biogen Inc 4.92%
Biomarin Pharmaceutical Inc 4.88%
ACADIA Pharmaceuticals Inc 4.84%
Amgen Inc 4.55%
PTC Therapeutics Inc 4.07%
Horizon Therapeutics plc Ordinary Shares 3.97%
Genmab A/S DKK1 3.41%
Neurocrine Biosciences Inc 3.16%
Sector Weight
Healthcare 85.40%
Country Weight
United States 72.54%
Denmark 6.16%
Switzerland 2.66%
Germany 1.40%
Netherlands 1.36%
China 0.53%
Ireland 0.43%
United Kingdom 0.30%

Key Dates

Launch date: 31 March 1994
Financial year end: August
Next AGM: December 2020
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.